Macquarie Group LTD Mannkind Corp Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.99 - $4.35 $18,011 - $26,204	-6,024 Closed	0 $19,000
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $23,433 - $33,011	6,024 New	6,024 $26,000
Q1 2018 May 11, 2018	SELL	$2.28 - $3.8 $37,346 - $62,244	-16,380 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$2.28 - $6.71 $126,311 - $371,734	-55,400 Reduced 77.18%	16,380 $38,000
Q3 2017 Nov 08, 2017	BUY	$1.15 - $2.29 $82,547 - $164,376	71,780	71,780 $156,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.